position: EnglishChannel  > News> More Patents Industrialized in 2022

More Patents Industrialized in 2022

Source: 科技日报 | 2023-01-11 23:14:50 | Author: 王晓夏


The fully automated terminal began?operation?at Nansha port in Guangzhou, capital of Guangdong province, on July 28, 2022,?having integrated advanced technologies such as Beidou navigation, 5G communications, artificial intelligence and autonomous vehicles.?(PHOTO:?XINHUA)

By?WANG?Xiaoxia

The industrialization rate of effective patents in China reached 36.7 percent in 2022, a record high in the past five years, according to an annual survey issued by China National Intellectual Property Administration (CNIPA), the country's top IP regulator, on December 28, 2022.

The rising patent industrialization rate reflects the continuous enhancement of China's ability to support the innovation and development of the real economy through the transfer and transformation of intellectual property rights.

According to the survey data, enterprises play a leading role in the improvement of patent industrialization across the country. For enterprise patentees, the patent industrialization rate was 48.1 percent in 2022, an increase of 1.3 percentage points over the previous year.

Among enterprises, those that are innovation-driven performed better, said Ge Shu, head of the strategic planning department at the CNIPA.

Most notably, the "national intellectual property demonstration enterprises," which is the highest honor awarded by the CNIPA for the creation, application, protection, and management of the intellectual property of an enterprise, saw their patent industrialization rate reach 61.3 percent, said Ge.


Editor:王晓夏

Top News

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.

抱歉,您使用的浏览器版本过低或开启了浏览器兼容模式,这会影响您正常浏览本网页

您可以进行以下操作:

1.将浏览器切换回极速模式

2.点击下面图标升级或更换您的浏览器

3.暂不升级,继续浏览

继续浏览